Kenvue Inc. (KVUE) Financial Statements
Historical financial data — 19 statements covering FY2021–FY2025
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and...
Kenvue Inc.'s revenue decreased 2.1% year over year, from $15.46B to $15.12B.
Net income increased 42.7% over the same period, from $1.03B to $1.47B.
Over the 4-year period from FY2021 to FY2025, revenue grew by 0% in total.
Total debt decreased by 6.4% to $1.45B.
The debt-to-equity ratio stands at 0.13, indicating a conservative leverage profile.
Operating cash flow grew 24.2% to $2.20B.
Kenvue Inc. maintains a moderate net profit margin of 9.7%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $3.90B-2.5% | $383.0M | $2.28B | $654.0M | $249.0M | $26.93B | $1.65B | $10.64B |
| Q4 FY2024 | $3.66B-6.1% | $293.0M | $2.07B | $483.0M | $793.0M | $25.60B | $1.55B | $9.67B |
| Q1 FY2025 | $3.74B+2.2% | $322.0M | $2.17B | $558.0M | $428.0M | $26.26B | $2.43B | $10.05B |
| Q2 FY2025 | $3.84B+2.6% | $420.0M | $2.26B | $692.0M | $621.0M | $27.13B | $1.55B | $10.73B |
| Q3 FY2025 | $3.76B-2.0% | $398.0M | $2.23B | $629.0M | $294.0M | $27.25B | $1.91B | $10.63B |
| Q4 FY2025 | $3.78B+0.4% | $330.0M | $2.14B | $535.0M | $854.0M | $27.08B | $1.45B | $10.77B |
| Q1 FY2026 | $3.91B+3.4% | $474.0M | $2.30B | $767.0M | $489.0M | $26.85B | $8.80B | $10.61B |
| Q2 FY2026 | $3.96B+1.2% | $456.0M | $2.30B | $699.0M | $688.0M | $26.73B | $8.61B | $10.55B |
Balance Sheet Summary (Q2 FY2026)
Kenvue Inc. (KVUE) Financial Statements & Revenue History
Kenvue Inc. (KVUE) is a US-listed stock operating in the Consumer Defensive sector, specifically the Perfumes, Cosmetics & Other Toilet Preparations industry trading at $18.85 with a market capitalization of $36. This page provides 19 historical financial statements for Kenvue Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Kenvue Inc. reported revenue of $15.1 billion, a 2.1% decline from the prior year. The net profit margin of 9.7% indicates moderate profitability. The debt-to-equity ratio of 0.13 shows conservative leverage.
KVUE Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Kenvue Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether KVUE is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track KVUE's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Kenvue Inc. converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of KVUE's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use KVUE Financial Data
Investors use Kenvue Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare KVUE's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how KVUE's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View KVUE's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Kenvue Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.KVUE trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.